April 24th 2025
New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Can DWI MRI Offer a Viable Non-Contrast Alternative for Breast Cancer Assessment?
October 19th 2023In a newly published literature review, researchers examined the benefits of diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) for breast cancer characterization and monitoring of neoadjuvant chemotherapy, current drawbacks that thwart wider adoption, and emerging techniques that may enhance the modality’s effectiveness.
Mammography-Based Deep Learning Model Facilitates Higher Breast Cancer Detection on Screening MRI
September 22nd 2023New research suggests the capability of a mammography-based deep learning model to identify women at high risk of breast cancer led to more than triple the cancer detection rate on breast MRI in comparison to traditional risk assessment tools.
AI Can Improve Tumor Mapping, Aid Patient Counseling in Focal Therapy for Prostate Cancer
August 31st 2023Wayne G. Brisbane, MD, of the University of California, Los Angeles, discussed the challenges of focal therapy for prostate cancer and how Unfold AI can help improve the accuracy of this treatment, as well as help counsel patients during the treatment decision process.
Study Reveals Tradeoffs Between Contrast-Enhanced Mammography and MRI for Supplemental Screening
August 16th 2023In a new study comparing standard breast MRI, abbreviated breast MRI and contrast-enhanced mammography in supplemental breast cancer screening, researchers found that MRI offered a greater than 14 percent higher cancer detection rate and a nearly 39 percent higher sensitivity rate than CEM.
MRI Study: Half-Dose Gadopiclenol Offers Similar Visualization and Safety as Full-Dose Gadobutrol
July 20th 2023Newly published research suggests the use of gadopiclenol at 0.05 mmol/kg is non-inferior to gadobutrol 0.1 mmol/kg for all qualitative visualization parameters on full-body magnetic resonance imaging (MRI).